As shown in Figure 2A, within subtypes of brain cancer, the top three mutation rates were MAD2L2/FANCV (21.49%) in meningioma, XRCC2/FANCU (17%) in rhabdoid tumors, and ATM (16%) in pediatric high-grade gliomas. The gene discussed is XRCC2; the disease is central nervous system cancer.